Mirovian Xr (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Mirovian Xr, is a Biguanide presented as an oral tablet for oral use. It is used to treat type 2 diabetes mellitus in adult patients. GNH USA supplies Mirovian Xr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin is used primarily in the management of disorders related to glucose metabolism, especially type 2 diabetes mellitus.

Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose levels.

Metformin is associated with a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, and loss of appetite. - Diarrhea: watery stools occurring especially after treatment initiation. - Metallic taste: transient alteration in taste perception. - Weight loss: modest reduction in body weight over time. - Vitamin B12 deficiency: gradual decrease in serum B12 levels with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening accumulation of lactate. - Severe skin reactions: including Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatotoxicity: abnormal liver function tests or hepatitis. - Hypoglycemia: when combined with insulin or insulin‑secretagogues. - Acute renal failure: especially in patients with pre‑existing kidney disease.

Metformin should be used with careful clinical assessment and monitoring. - Renal function: assess creatinine clearance before initiation and periodically thereafter. - Hepatic function: avoid in patients with significant liver disease. - Alcohol consumption: limit intake to reduce risk of lactic acidosis. - Concomitant drugs: review for agents that may impair renal function or increase metformin levels. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Store at room temperature: keep in the original container, protect from moisture and heat.

Metformin may interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Iodinated contrast agents: can precipitate acute renal failure. - Cimetidine: may increase metformin plasma concentrations. - Alcohol: potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Sulfonylureas or insulin: increased risk of hypoglycemia. - Diuretics: may affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and electrolytes. - Beta‑blockers: may mask hypoglycemia symptoms. - Oral corticosteroids: can raise blood glucose, requiring dose adjustments.